Our data showed that R-Ras expression was strongly correlated with TMEM158 expression (Spearman r = 0.558, p < 0.001), and both TMEM158 and R-Ras expression levels were significantly reduced in prostate cancer tissues. Here, RRAS is linked to prostate carcinoma.